logo
15:53 Dec 05

Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1551.70
-8.20 (-0.53%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Eris Lifesciences Ltd. Financials

Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1551.70
-8.20 (-0.53%)
15:53 Dec 05
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

42/100
Technically Neutral

Strength

7

Weakness

8

Opportunity

0

Threats

0

12.32 %

ROE %

5.00 %

ROA %

30.51

EPS

209.57

BVPS

12.15 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1347.04 1685.15 2009.14 2893.64 2944.7
Operating Expenses +
862.09 1148.4 1334.32 1876.44 1903
Raw Material
259.29 348.53 379.33 749.46 731.78
Increase Decrease in Cost
-0.78 3.82 0.72 -35.47 -13.74
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
252.25 346.16 403.82 505.09 516.9
Miscellaneous Expenses
634.77 862.55 953.49 1603.6 668.06
Operating Profit
484.95 536.75 674.82 1017.2 1041.7
Other Income
26.09 11.15 23.82 18.36 21.63
Depreciation
64.7 117.09 182.6 315.46 309.44
Interest
4.15 26.17 84.8 231.29 219.6
Profit before tax and exceptio..
442.2 404.64 431.24 488.81 534.29
Exceptional Items
0 0 0 0 0
PBT
442.2 404.64 431.24 488.81 534.29
Provision for Taxation
36.41 30.48 34.18 114.2 124.51
Net Profit
405.79 374.16 397.05 374.61 409.78
NET Profit after MI
406.11 382.16 391.98 351.84 387.05
EPS
29.89 28.1 28.82 25.81 28.44
Operating Profit Margin (%)
36 31.85 33.59 35.15 35.38
Net Profit Margin (%)
30.15 22.68 19.51 12.16 13.14

Eris Lifesciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 54.80 54.80 54.80 54.90 54.90 54.90
FII 7.20 8.40 8.40 8.40 8.00 14.60
Public 19.40 18.20 18.10 18.00 18.60 16.20
Others 18.60 18.60 18.70 18.70 18.50 14.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: